✦ LIBER ✦

Refractory immune thrombocytopenic purpura in pregnancy, managed with multiple courses of high dose immunoglobulin

✍ Scribed by G. Burke; C. Casey; P. Chamberlain; E. Egan; F. P. Meehan

Book ID: 112946973
Publisher: Springer-Verlag
Year: 1989
Tongue: English
Weight: 151 KB
Volume: 158
Category: Article
ISSN: 1863-4362
DOI: 10.1007/bf02942146

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of refractory chronic idiopath

Treatment of refractory chronic idiopathic thrombocytopenic purpura with high dose intravenous immunoglobulin

✍ Seifried, E. ;Pindur, G. ;St�tter, H. ;Wiesneth, M. ;Rasche, H. ;Heimpel, H. 📂 Article 📅 1984 🏛 Springer-Verlag ⚖ 473 KB

Three patients with a history of chronic idiopathic thrombocytopenic purpura stretching back over 20 years are reported. Despite splenectomy and immunosuppressive therapy satisfactory control of their disease has not been achieved. They had remained refractory to all therapeutic manoeuvres with cort

High-dose intravenous igg in the managem

High-dose intravenous igg in the management of pregnancy in women with idiopathic thrombocytopenic purpura

✍ Dr. Emmanuel C. Besa; Malcolm W. Macnab; Andrew J. Solan; Melvin J. Lapes; Usha 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 2 views

Failure of repeated courses of high-dose

Failure of repeated courses of high-dose intravenous immunoglobulin to induce stable remission in patients with chronic idiopathic thrombocytopenic purpura

✍ C. Schiavotto; M. Ruggeri; F. Rodeghiero 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 188 KB

Safety and tolerability of a novel chrom

Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpura

✍ James B. Bussel; Kim Hanna 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Abstract Intravenous immunoglobulin (IGIV) therapy is generally considered to be a safe and effective treatment for idiopathic thrombocytopenic purpura (ITP). The usual initial treatment dose is 1–2 g/kg body weight, which results in an extended infusion time, significantly impacting patients' d